GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Institutional Ownership

BioDelivery Sciences International (FRA:BD5) Institutional Ownership : 35.26% (As of May. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioDelivery Sciences International's institutional ownership is 35.26%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioDelivery Sciences International's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioDelivery Sciences International's Float Percentage Of Total Shares Outstanding is 85.83%.


BioDelivery Sciences International Institutional Ownership Historical Data

The historical data trend for BioDelivery Sciences International's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Institutional Ownership Chart

BioDelivery Sciences International Historical Data

The historical data trend for BioDelivery Sciences International can be seen below:

2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31
Institutional Ownership 56.41 56.86 56.51 53.80 53.82 51.09 46.72 42.29 38.37 35.26

BioDelivery Sciences International Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines